# Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension

> **NCT00858702** · PHASE4 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 105 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** olmesartan medoxomil and a CCB
- **DRUG:** olmesartan medoxomil and a diuretic

## Key facts

- **NCT ID:** NCT00858702
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-07
- **Final completion:** 2005-11
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2017-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858702, "Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00858702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*